相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Differentiation of Hodgkin lymphoma cells by reactive oxygen species and regulation by heme oxygenase-1 through HIF-1α
Makoto Nakashima et al.
CANCER SCIENCE (2021)
Impact of hypoxia on the pathogenesis and therapy resistance in multiple myeloma
Sho Ikeda et al.
CANCER SCIENCE (2021)
Hypoxia-induced ROS promotes mitochondrial fission and cisplatin chemosensitivity via HIF-1α/Mff regulation in head and neck squamous cell carcinoma
Kun Wu et al.
CELLULAR ONCOLOGY (2021)
Heme oxygenase-1 inhibition mediates Gas6 to enhance bortezomib-sensitivity in multible myeloma via ERK/STAT3 axis
Zhaoyuan Zhang et al.
AGING-US (2020)
Hypoxia-inducible hexokinase-2 enhances anti-apoptotic function via activating autophagy in multiple myeloma
Sho Ikeda et al.
CANCER SCIENCE (2020)
Targeting Ferroptosis to Iron Out Cancer
Behrouz Hassannia et al.
CANCER CELL (2019)
Histone deacetylase inhibitor LMK-235-mediated HO-1 expression induces apoptosis in multiple myeloma cells via the JNK/AP-1 signaling pathway
Xinyao Li et al.
LIFE SCIENCES (2019)
Mitochondrial fission causes cisplatin resistance under hypoxic conditions via ROS in ovarian cancer cells
Youngjin Han et al.
ONCOGENE (2019)
Heme oxygenase-1 attenuates the inhibitory effect of bortezomib against the APRIL-NF-κB-CCL3 signaling pathways in multiple myeloma cells: Corelated with bortezomib tolerance in multiple myeloma
Zheng C. He et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
Multiple myeloma cells adapted to long-exposure of hypoxia exhibit stem cell characters with TGF-β/Smad pathway activation
Yoko Nakagawa et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
MAFb protein confers intrinsic resistance to proteasome inhibitors in multiple myeloma
Ya-Wei Qiang et al.
BMC CANCER (2018)
Hypoxia-inducible KDM3A addiction in multiple myeloma
Sho Ikeda et al.
BLOOD ADVANCES (2018)
Leukemic stem cells: identification and clinical application
Diana Hanekamp et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2017)
Mitochondrial composition and function under the control of hypoxia
Dominik C. Fuhrmann et al.
REDOX BIOLOGY (2017)
Hypoxia-inducible microRNA-210 regulates the DIMT1-IRF4 oncogenic axis in multiple myeloma
Sho Ikeda et al.
CANCER SCIENCE (2017)
Drug resistance and cancer stem cells: the shared but distinct roles of hypoxia-inducible factors HIF1α and HIF2α
Jennifer Petra Schoning et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2017)
Mitochondrial thioredoxin reductase regulates major cytotoxicity pathways of proteasome inhibitors in multiple myeloma cells
E. E. Fink et al.
LEUKEMIA (2016)
Progression of a solitary plasmacytoma to multiple myeloma. A population-based registry of the northern Netherlands
Esther G. M. de Waal et al.
BRITISH JOURNAL OF HAEMATOLOGY (2016)
Potential crosstalk of the interleukin-6-heme oxygenase-1-dependent mechanism involved in resistance to lenalidomide in multiple myeloma cells
Weibing Wu et al.
FEBS JOURNAL (2016)
Hypoxia-induced oxidative stress promotes MUC4 degradation via autophagy to enhance pancreatic cancer cells survival
S. Joshi et al.
ONCOGENE (2016)
Metabolic Signature Identifies Novel Targets for Drug Resistance in Multiple Myeloma
Patricia Maiso et al.
CANCER RESEARCH (2015)
Dynamic balance of multiple myeloma clonogenic side population cell percentages controlled by environmental conditions
Jianguo Wen et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Concise Review: Defining and Targeting Myeloma Stem Cell-Like Cells
Masahiro Abe et al.
STEM CELLS (2014)
Hypoxia promotes stem cell-like phenotype in multiple myeloma cells
B. Muz et al.
BLOOD CANCER JOURNAL (2014)
Hypoxia reduces CD138 expression and induces an immature and stem cell-like transcriptional program in myeloma cells
Yawara Kawano et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
Bortezomib Reduces the Tumorigenicity of Multiple Myeloma via Downregulation of Upregulated Targets in Clonogenic Side Population Cells
Miho Nara et al.
PLOS ONE (2013)
Hypoxia promotes dissemination of multiple myeloma through acquisition of epithelial to mesenchymal transition-like features
Abdel Kareem Azab et al.
BLOOD (2012)
Bortezomib induces heme oxygenase-1 expression in multiple myeloma
Lawrence N. Barrera et al.
CELL CYCLE (2012)
DyeCycle violet used for side population detection is a substrate of P-glycoprotein
Maximilian Boesch et al.
CYTOMETRY PART A (2012)
Hypoxia improves expansion potential of human cord blood-derived hematopoietic stem cells and marrow repopulation efficiency
Sushmita Roy et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2012)
A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC Myeloma IX trial
K. D. Boyd et al.
LEUKEMIA (2012)
Lenalidomide targets clonogenic side population in multiple myeloma: pathophysiologic and clinical implications
Jana Jakubikova et al.
BLOOD (2011)
Oxygen Sensing, Homeostasis, and Disease
David De Bels et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
MEDICAL PROGRESS Multiple Myeloma
Antonio Palumbo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
MECHANISMS OF DISEASE Oxygen Sensing, Homeostasis, and Disease
Gregg L. Semenza
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Expression of heme oxygenase-1 in human leukemic cells and its regulation by transcriptional repressor Bach1
Takuya Miyazaki et al.
CANCER SCIENCE (2010)
Mitochondrial reactive oxygen species regulate hypoxic signaling
Robert B. Hamanaka et al.
CURRENT OPINION IN CELL BIOLOGY (2009)
Identification of primary MAFB target genes in multiple myeloma
Esther van Stralen et al.
EXPERIMENTAL HEMATOLOGY (2009)
Redox homeostasis modulates the sensitivity of myeloma cells to bortezomib Redox homeostasis modulates the sensitivity of myeloma cells to bortezomib
Silvia Nerini-Molteni et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Regulation of gene expression by hypoxia:: Integration of the HIF-transduced hypoxic signal at the hypoxia-responsive element
Stefan Kaluz et al.
CLINICA CHIMICA ACTA (2008)
The histone deacetylase inhibitor, PXD101, potentiates bortezomib-induced anti-multiple myeloma effect by induction of oxidative stress and DNA damage
Rentian Feng et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Overexpression of c-maf is a frequent oncogenic event in multiple myeloma that promotes proliferation and pathological interactions with bone marrow stroma
EM Hurt et al.
CANCER CELL (2004)
The recurrent translocation t(14;20)(q32;q12) in multiple myeloma results in aberrant expression of MAFB:: a molecular and genetic analysis of the chromosomal breakpoint
GR Boersma-Vreugdenhil et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
Synergistic induction of oxidative injury and apoptosis in human multiple myeloma cells by the proteasome inhibitor bortezomib and histone deacetylase inhibitors
XY Pei et al.
CLINICAL CANCER RESEARCH (2004)
Antiapoptotic role of heme oxygenase (HO) and the potential of HO as a target in anticancer treatment
J Fang et al.
APOPTOSIS (2004)
Ectopic expression of MAFB gene in human myeloma cells carrying (14;20)(q32;q11) chromosomal translocations
I Hanamura et al.
JAPANESE JOURNAL OF CANCER RESEARCH (2001)
HIFα targeted for VHL-mediated destruction by proline hydroxylation:: Implications for O2 sensing
M Ivan et al.
SCIENCE (2001)
Targeting of HIF-α to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation
P Jaakkola et al.
SCIENCE (2001)
分享论文
